In a small, red, oval-shaped box, a vending machine is tucked away inside a white box.
Inside is a small plastic cube.
Inside that box, the FDA has a vending device.
In it, a tiny tube of the drug is inserted into a vending dish.
In a few days, the device will dispense a small dose of the medicine in a small capsule.
The FDA says the device is called a centrifugal injection pump.
It’s meant to help people who have suffered kidney damage.
The device is part of a larger effort to help treat people who’ve had a heart attack.
The device has been tested on 1,300 people.
There’s been no human study of it.
It was approved in April to treat people with severe kidney damage who’ve suffered a heart or blood vessel blockage.
The machines are not FDA-approved, but it’s the FDA that approved the device.
The FDA says it’s in the process of reviewing the device and its effects on people with kidney damage, but won’t say when that will happen.
“I think this is really exciting,” said Sarah Wieder, a cardiologist at the University of Pennsylvania Medical School who’s working with the FDA on a study on the device’s effects on heart failure.
“I think it will be great to see more studies that we can use to understand what we’re doing, to see if this is going to work for us, and if we need to get this device in people’s hands, as quickly as possible.”
The FDA doesn’t have a timeline for when the device could be on the market, and Wieders hopes to start clinical trials in 2018.
She’s also looking for more funding for the device to go into people with more severe heart failure, and the other kidney damage patients.
For now, Wieds the machine is a good way to treat patients with kidney pain.
“This is the first time I’ve ever been able to do this safely, and it’s a good feeling,” she said.
But for others, it’s not a good feel.
Some doctors, including some with a heart disease specialty, worry the device may increase the number of people with heart disease.
That’s because the device might also increase the chance of people getting heart attack and stroke.
The Food and Drug Administration says it can’t approve the device without a more detailed study.
That study could take several years, and a final decision will be made by the FDA’s board of commissioners.
The pill will cost $35.95 and can be purchased online at drugstore.gov.
It also can be bought in vending machines at health food stores, pharmacies, health clubs, hospitals and other pharmacies.
The Drug Enforcement Administration says the drug won’t be sold in hospitals, but the FDA says doctors and patients with heart attack or stroke can use the device at home to treat severe kidney injury.